Hide and CancerSEEK.

Sorry, USPTSF, but we’re not over ovarian cancer screening just yet. A new blood test developed at Johns Hopkins called CancerSEEK touts the ability to simultaneously screen for the presence of circulating tumor DNA from 8 different malignancies responsible for 60% of all cancer deaths, 5 of which currently have no screening options--including, you guessed it, ovarian cancer. We smell liquid gold.